CN Stock MarketDetailed Quotes

688302 Hinova Pharmaceuticals Inc.

Watchlist
  • 26.50
  • +0.23+0.88%
Market Closed Jun 7 15:00 CST
2.62BMarket Cap-9865P/E (TTM)

Hinova Pharmaceuticals Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
-64.16%283.46M
-32.32%813.23M
167.97%738.54M
-43.78%780.7M
-2.54%790.8M
33.33%1.2B
--275.61M
31.08%1.39B
--811.4M
-20.85%901.22M
Transactional financial assets
5.76%736.29M
-20.65%290.62M
-66.91%470.37M
47.14%517.26M
--696.2M
--366.24M
--1.42B
--351.55M
----
----
Other receivables (including interest and dividends)
-43.71%969.59K
-17.10%1.39M
-19.26%1.44M
-17.21%1.42M
134.25%1.72M
207.53%1.67M
--1.78M
645.98%1.71M
--735.34K
294.51%543.75K
-Other receivable
----
-17.10%1.39M
----
-17.21%1.42M
----
207.53%1.67M
----
645.98%1.71M
----
294.51%543.75K
Advance payment
21.25%33.54M
21.67%30.05M
127.64%37.46M
9.79%28.83M
-4.56%27.67M
-20.20%24.7M
--16.45M
-8.88%26.26M
--28.99M
-16.48%30.95M
Inventories
25.97%5.17K
-13.94%5.58K
-15.97%4.41K
15.79%4.61K
-22.13%4.1K
31.82%6.48K
--5.25K
-20.57%3.98K
--5.27K
8.67%4.92K
Other current assets
-15.70%17.08M
-30.13%11.93M
9.03%17.98M
0.77%14.35M
-23.71%20.26M
-24.16%17.08M
--16.49M
38.61%14.24M
--26.56M
244.57%22.52M
Total current assets
-30.28%1.07B
-28.80%1.15B
-26.91%1.27B
-24.68%1.34B
77.10%1.54B
68.68%1.61B
--1.73B
62.23%1.78B
--867.69M
-19.21%955.24M
Non Current assets
Other non-current financial assets
40.65%7.03M
40.65%7.03M
--5M
--5M
--5M
--5M
----
----
----
----
Fixed assets
----
-16.62%5.84M
----
2.79%6.53M
----
35.41%7.01M
----
30.39%6.35M
----
21.34%5.18M
Fixed assets liquidation
----
--1.03K
----
--709.74
----
----
----
----
----
----
Constru in process
----
129.86%169.54M
----
1,574.04%117.43M
----
2,361.02%73.76M
----
322.46%7.01M
----
--3M
Intangible assets
-2.05%31.05M
-2.04%31.21M
-2.03%31.37M
-2.02%31.53M
-2.17%31.7M
--31.86M
--32.02M
--32.18M
--32.4M
----
Long deferred expense
-57.14%30.92K
-50.00%41.23K
-44.44%51.54K
-40.00%61.85K
-36.36%72.16K
--82.46K
--92.77K
-67.72%103.08K
--113.39K
----
Usufruct assets
-26.52%11.58M
115.56%12.61M
101.08%13.66M
106.91%14.71M
98.02%15.77M
28.72%5.85M
--6.79M
119.96%7.11M
--7.96M
584.70%4.54M
Other non current assets
56,787.75%109.27M
56,508.54%118.07M
18,371.52%116.89M
14,478.24%111.37M
-87.14%192.08K
-98.55%208.56K
--632.81K
26.63%763.93K
--1.49M
2,334.08%14.39M
Total non current assets
136.38%363.09M
178.22%344.34M
356.33%309.94M
435.51%286.64M
201.91%153.6M
356.57%123.76M
--67.92M
400.91%53.53M
--50.88M
340.96%27.11M
Total assets
-15.13%1.43B
-14.03%1.49B
-12.45%1.58B
-11.26%1.63B
84.01%1.69B
76.62%1.74B
--1.8B
65.49%1.84B
--918.57M
-17.34%982.35M
Liabilities
Current liabilities
Short term loan
----
----
--30M
--30M
--30M
--30M
----
----
----
----
Notes payable and accounts payable
-20.60%77.6M
3.23%92.87M
41.39%107.07M
60.67%103.21M
20.79%97.73M
8.34%89.96M
--75.73M
-9.93%64.24M
--80.91M
57.67%83.03M
-Accounts payable
-20.60%77.6M
3.23%92.87M
41.39%107.07M
60.67%103.21M
20.79%97.73M
8.34%89.96M
--75.73M
-9.93%64.24M
--80.91M
57.67%83.03M
Salaries payable
-46.72%3.2M
-45.56%4.96M
-19.47%7.38M
100.92%9.74M
171.71%6M
5.14%9.12M
--9.16M
164.56%4.85M
--2.21M
75.94%8.67M
Taxs payable
1,651.34%978.77K
54.77%1.22M
2,098.01%1.09M
-58.52%286.57K
-83.32%55.89K
1,199.51%785.1K
--49.43K
281.23%690.88K
--335.06K
-69.44%60.41K
Other payable (including interest and dividends)
28.18%5.05M
-32.42%4.03M
-27.51%4.23M
-16.07%4.27M
-25.26%3.94M
2.14%5.96M
--5.84M
-12.28%5.09M
--5.27M
12.26%5.84M
-Other payable
----
-32.42%4.03M
----
-16.07%4.27M
----
2.14%5.96M
----
-12.28%5.09M
----
12.26%5.84M
Non current liabilities due within one year
-8.68%3.76M
54.06%3.77M
-93.94%4.13M
-93.61%4.31M
-95.67%4.12M
-97.39%2.45M
--68.11M
4,155.16%67.44M
--95.15M
40,614.32%93.73M
Total current liabilities
-36.14%90.58M
-22.73%106.84M
-3.14%153.89M
6.68%151.82M
-22.86%141.84M
-27.73%138.27M
--158.88M
-34.73%142.3M
--183.87M
-4.10%191.33M
Current liabilities
Long term deferred income
5.56%8.55M
5.56%8.55M
1,990.32%8.1M
1,308.70%8.1M
839.13%8.1M
604.35%8.1M
--387.5K
-68.06%575K
--862.5K
-53.06%1.15M
Lease liabilities
-17.52%9.21M
174.22%9.08M
160.91%9.6M
161.02%10.28M
170.86%11.17M
198.25%3.31M
--3.68M
225.50%3.94M
--4.12M
211.27%1.11M
Total non current liabilities
-7.82%17.76M
54.50%17.63M
335.17%17.7M
307.29%18.38M
286.49%19.27M
404.87%11.41M
--4.07M
49.92%4.51M
--4.98M
-19.47%2.26M
Total liabilities
-32.75%108.34M
-16.84%124.47M
5.30%171.59M
15.92%170.19M
-14.70%161.11M
-22.68%149.68M
--162.95M
-33.58%146.82M
--188.86M
-4.32%193.59M
Shareholders equity
Paid-in capital
0.00%99.02M
0.00%99.02M
0.00%99.02M
0.00%99.02M
33.34%99.02M
33.34%99.02M
--99.02M
33.34%99.02M
--74.26M
0.00%74.26M
Capital reserve funds
2.52%2.56B
3.06%2.56B
3.43%2.54B
3.64%2.52B
74.08%2.5B
76.16%2.48B
--2.45B
80.09%2.43B
--1.44B
8.37%1.41B
Retained profit
-24.83%-1.34B
-29.53%-1.29B
-34.57%-1.23B
-37.85%-1.16B
-37.11%-1.07B
-43.41%-996.06M
---917.07M
-57.04%-842.41M
---781.44M
-78.84%-694.54M
Other composite income
44.12%135.89K
-19.02%109.51K
263.76%264.99K
15.56%288.88K
212.99%94.29K
284.26%135.24K
--72.85K
570.69%249.98K
---83.45K
-64.37%-73.4K
Shareholders equity without minority interests
-13.28%1.33B
-13.77%1.37B
-14.21%1.4B
-13.63%1.46B
109.55%1.53B
101.00%1.59B
--1.64B
90.14%1.69B
--729.71M
-20.02%788.76M
Total shareholder equity
-13.28%1.33B
-13.77%1.37B
-14.21%1.4B
-13.63%1.46B
109.55%1.53B
101.00%1.59B
--1.64B
90.14%1.69B
--729.71M
-20.02%788.76M
Total liabilityies and equity
-15.13%1.43B
-14.03%1.49B
-12.45%1.58B
-11.26%1.63B
84.01%1.69B
76.62%1.74B
--1.8B
65.49%1.84B
--918.57M
-17.34%982.35M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)
--
--
--
Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)
--
--
--
Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds -64.16%283.46M-32.32%813.23M167.97%738.54M-43.78%780.7M-2.54%790.8M33.33%1.2B--275.61M31.08%1.39B--811.4M-20.85%901.22M
Transactional financial assets 5.76%736.29M-20.65%290.62M-66.91%470.37M47.14%517.26M--696.2M--366.24M--1.42B--351.55M--------
Other receivables (including interest and dividends) -43.71%969.59K-17.10%1.39M-19.26%1.44M-17.21%1.42M134.25%1.72M207.53%1.67M--1.78M645.98%1.71M--735.34K294.51%543.75K
-Other receivable -----17.10%1.39M-----17.21%1.42M----207.53%1.67M----645.98%1.71M----294.51%543.75K
Advance payment 21.25%33.54M21.67%30.05M127.64%37.46M9.79%28.83M-4.56%27.67M-20.20%24.7M--16.45M-8.88%26.26M--28.99M-16.48%30.95M
Inventories 25.97%5.17K-13.94%5.58K-15.97%4.41K15.79%4.61K-22.13%4.1K31.82%6.48K--5.25K-20.57%3.98K--5.27K8.67%4.92K
Other current assets -15.70%17.08M-30.13%11.93M9.03%17.98M0.77%14.35M-23.71%20.26M-24.16%17.08M--16.49M38.61%14.24M--26.56M244.57%22.52M
Total current assets -30.28%1.07B-28.80%1.15B-26.91%1.27B-24.68%1.34B77.10%1.54B68.68%1.61B--1.73B62.23%1.78B--867.69M-19.21%955.24M
Non Current assets
Other non-current financial assets 40.65%7.03M40.65%7.03M--5M--5M--5M--5M----------------
Fixed assets -----16.62%5.84M----2.79%6.53M----35.41%7.01M----30.39%6.35M----21.34%5.18M
Fixed assets liquidation ------1.03K------709.74------------------------
Constru in process ----129.86%169.54M----1,574.04%117.43M----2,361.02%73.76M----322.46%7.01M------3M
Intangible assets -2.05%31.05M-2.04%31.21M-2.03%31.37M-2.02%31.53M-2.17%31.7M--31.86M--32.02M--32.18M--32.4M----
Long deferred expense -57.14%30.92K-50.00%41.23K-44.44%51.54K-40.00%61.85K-36.36%72.16K--82.46K--92.77K-67.72%103.08K--113.39K----
Usufruct assets -26.52%11.58M115.56%12.61M101.08%13.66M106.91%14.71M98.02%15.77M28.72%5.85M--6.79M119.96%7.11M--7.96M584.70%4.54M
Other non current assets 56,787.75%109.27M56,508.54%118.07M18,371.52%116.89M14,478.24%111.37M-87.14%192.08K-98.55%208.56K--632.81K26.63%763.93K--1.49M2,334.08%14.39M
Total non current assets 136.38%363.09M178.22%344.34M356.33%309.94M435.51%286.64M201.91%153.6M356.57%123.76M--67.92M400.91%53.53M--50.88M340.96%27.11M
Total assets -15.13%1.43B-14.03%1.49B-12.45%1.58B-11.26%1.63B84.01%1.69B76.62%1.74B--1.8B65.49%1.84B--918.57M-17.34%982.35M
Liabilities
Current liabilities
Short term loan ----------30M--30M--30M--30M----------------
Notes payable and accounts payable -20.60%77.6M3.23%92.87M41.39%107.07M60.67%103.21M20.79%97.73M8.34%89.96M--75.73M-9.93%64.24M--80.91M57.67%83.03M
-Accounts payable -20.60%77.6M3.23%92.87M41.39%107.07M60.67%103.21M20.79%97.73M8.34%89.96M--75.73M-9.93%64.24M--80.91M57.67%83.03M
Salaries payable -46.72%3.2M-45.56%4.96M-19.47%7.38M100.92%9.74M171.71%6M5.14%9.12M--9.16M164.56%4.85M--2.21M75.94%8.67M
Taxs payable 1,651.34%978.77K54.77%1.22M2,098.01%1.09M-58.52%286.57K-83.32%55.89K1,199.51%785.1K--49.43K281.23%690.88K--335.06K-69.44%60.41K
Other payable (including interest and dividends) 28.18%5.05M-32.42%4.03M-27.51%4.23M-16.07%4.27M-25.26%3.94M2.14%5.96M--5.84M-12.28%5.09M--5.27M12.26%5.84M
-Other payable -----32.42%4.03M-----16.07%4.27M----2.14%5.96M-----12.28%5.09M----12.26%5.84M
Non current liabilities due within one year -8.68%3.76M54.06%3.77M-93.94%4.13M-93.61%4.31M-95.67%4.12M-97.39%2.45M--68.11M4,155.16%67.44M--95.15M40,614.32%93.73M
Total current liabilities -36.14%90.58M-22.73%106.84M-3.14%153.89M6.68%151.82M-22.86%141.84M-27.73%138.27M--158.88M-34.73%142.3M--183.87M-4.10%191.33M
Current liabilities
Long term deferred income 5.56%8.55M5.56%8.55M1,990.32%8.1M1,308.70%8.1M839.13%8.1M604.35%8.1M--387.5K-68.06%575K--862.5K-53.06%1.15M
Lease liabilities -17.52%9.21M174.22%9.08M160.91%9.6M161.02%10.28M170.86%11.17M198.25%3.31M--3.68M225.50%3.94M--4.12M211.27%1.11M
Total non current liabilities -7.82%17.76M54.50%17.63M335.17%17.7M307.29%18.38M286.49%19.27M404.87%11.41M--4.07M49.92%4.51M--4.98M-19.47%2.26M
Total liabilities -32.75%108.34M-16.84%124.47M5.30%171.59M15.92%170.19M-14.70%161.11M-22.68%149.68M--162.95M-33.58%146.82M--188.86M-4.32%193.59M
Shareholders equity
Paid-in capital 0.00%99.02M0.00%99.02M0.00%99.02M0.00%99.02M33.34%99.02M33.34%99.02M--99.02M33.34%99.02M--74.26M0.00%74.26M
Capital reserve funds 2.52%2.56B3.06%2.56B3.43%2.54B3.64%2.52B74.08%2.5B76.16%2.48B--2.45B80.09%2.43B--1.44B8.37%1.41B
Retained profit -24.83%-1.34B-29.53%-1.29B-34.57%-1.23B-37.85%-1.16B-37.11%-1.07B-43.41%-996.06M---917.07M-57.04%-842.41M---781.44M-78.84%-694.54M
Other composite income 44.12%135.89K-19.02%109.51K263.76%264.99K15.56%288.88K212.99%94.29K284.26%135.24K--72.85K570.69%249.98K---83.45K-64.37%-73.4K
Shareholders equity without minority interests -13.28%1.33B-13.77%1.37B-14.21%1.4B-13.63%1.46B109.55%1.53B101.00%1.59B--1.64B90.14%1.69B--729.71M-20.02%788.76M
Total shareholder equity -13.28%1.33B-13.77%1.37B-14.21%1.4B-13.63%1.46B109.55%1.53B101.00%1.59B--1.64B90.14%1.69B--729.71M-20.02%788.76M
Total liabilityies and equity -15.13%1.43B-14.03%1.49B-12.45%1.58B-11.26%1.63B84.01%1.69B76.62%1.74B--1.8B65.49%1.84B--918.57M-17.34%982.35M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion--------
Auditor --Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)------Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)------Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg